DK120390D0 - Nasal administration af benzodiazepinhypnotika - Google Patents

Nasal administration af benzodiazepinhypnotika

Info

Publication number
DK120390D0
DK120390D0 DK120390A DK120390A DK120390D0 DK 120390 D0 DK120390 D0 DK 120390D0 DK 120390 A DK120390 A DK 120390A DK 120390 A DK120390 A DK 120390A DK 120390 D0 DK120390 D0 DK 120390D0
Authority
DK
Denmark
Prior art keywords
nasal administration
benzodiazepine hypnotics
benzodiazepine
nasal
hypnotics
Prior art date
Application number
DK120390A
Other languages
English (en)
Other versions
DK175710B1 (da
DK120390A (da
Inventor
Arthur H Goldberg
Original Assignee
Arthur H Goldberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22925038&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK120390(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Arthur H Goldberg filed Critical Arthur H Goldberg
Publication of DK120390A publication Critical patent/DK120390A/da
Publication of DK120390D0 publication Critical patent/DK120390D0/da
Application granted granted Critical
Publication of DK175710B1 publication Critical patent/DK175710B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
DK199001203A 1988-09-16 1990-05-15 Nasal administration af benzodiazepinhypnotika DK175710B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/245,031 US4950664A (en) 1988-09-16 1988-09-16 Nasal administration of benzodiazepine hypnotics
US24503188 1988-09-16
US8903897 1989-09-08
PCT/US1989/003897 WO1990002737A1 (en) 1988-09-16 1989-09-08 Nasal administration of benzodiazepine hypnotics

Publications (3)

Publication Number Publication Date
DK120390A DK120390A (da) 1990-05-15
DK120390D0 true DK120390D0 (da) 1990-05-15
DK175710B1 DK175710B1 (da) 2005-01-31

Family

ID=22925038

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199001203A DK175710B1 (da) 1988-09-16 1990-05-15 Nasal administration af benzodiazepinhypnotika

Country Status (12)

Country Link
US (1) US4950664A (da)
EP (1) EP0386232B2 (da)
JP (1) JP2729525B2 (da)
KR (1) KR920005965B1 (da)
AT (1) ATE125799T1 (da)
AU (1) AU640618B2 (da)
CA (1) CA1336502C (da)
DE (1) DE68923697T3 (da)
DK (1) DK175710B1 (da)
IL (1) IL91656A0 (da)
NZ (1) NZ230653A (da)
WO (1) WO1990002737A1 (da)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE36744E (en) * 1988-09-16 2000-06-20 Ribogene, Inc. Nasal administration of benzodiazepine hypnotics
EP0532546B1 (en) * 1990-05-10 1998-03-18 Bechgaard International Research And Development A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
US5166202A (en) * 1990-09-19 1992-11-24 Trustees Of The University Of Pennsylvania Method for the treatment of panic disorder
CA2055308A1 (en) * 1990-11-29 1992-05-30 Roman Amrein Imidazobenzodiazepine for the treatment of sleep disorders
US5679580A (en) * 1994-03-09 1997-10-21 Midwest Research Institute Rapid evaporation method for analysis
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
WO1996011689A1 (en) * 1994-10-14 1996-04-25 Glaxo Wellcome Spa Use of cck-b receptor antagonists for the treatment of sleep disorders
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
KR100715513B1 (ko) 1999-07-26 2007-05-08 에스케이 코오포레이션 경비 항경련성 조성물
DK1464641T3 (da) * 1999-12-30 2008-08-18 Lundbeck & Co As H 4-phenylpiperazinyl-, -piperidinyl- og -tetrahydropyridylderivater som dopamin-D4-antagonister
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
US6610271B2 (en) * 2000-05-10 2003-08-26 University Of Kentucky Research Foundation System and method for intranasal administration of lorazepam
JP2004505730A (ja) * 2000-08-15 2004-02-26 ユニバーシティ　オブ　ケンタッキー　リサーチ　ファウンデーション プログラム可能多用量鼻腔内薬物送達デバイス
US20040176359A1 (en) * 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
JP2005503425A (ja) 2001-05-24 2005-02-03 アレックザ モレキュラー デリヴァリー コーポレイション 所定の吸入ルートによる薬剤エステルの送出
EP1392258B1 (en) 2001-05-24 2008-11-26 Alexza Pharmaceuticals, Inc. Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
US7138107B2 (en) * 2003-02-18 2006-11-21 Compellis Pharmaceuticals Inhibition of olfactory neurosensory function to treat eating disorders and obesity
US20040241100A1 (en) * 2003-03-17 2004-12-02 Fabre Kramer Pharmaceutical, Inc. Nasally administrable compositions of zolpidem and methods of use
KR20060012030A (ko) * 2003-06-17 2006-02-06 에스케이 주식회사 디아제팜을 함유하는 경비 마이크로에멀젼
GB0400804D0 (en) * 2004-01-14 2004-02-18 Innoscience Technology Bv Pharmaceutical compositions
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US20060039869A1 (en) * 2004-08-17 2006-02-23 Daniel Wermeling Intranasal delivery of antipsychotic drugs
TW200824693A (en) * 2006-08-28 2008-06-16 Jazz Pharmaceuticals Inc Pharmaceutical compositions of clonazepam and methods of use thereof
US7745430B2 (en) * 2006-11-15 2010-06-29 Sk Holdings Co., Ltd. Transnasal anticonvulsive pharmaceutical composition
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
EP2121088B1 (en) 2007-03-09 2016-07-13 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
CN101842079B (zh) * 2007-08-31 2012-09-05 阿基米德开发有限公司 非水性药物组合物
KR101517415B1 (ko) 2008-05-14 2015-05-07 에스케이바이오팜 주식회사 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물
WO2012135536A1 (en) * 2011-04-01 2012-10-04 Cpex Pharmaceuticals, Inc. Nasal formulations of benzodiazepine
JP2016171366A (ja) * 2015-03-11 2016-09-23 キヤノン株式会社 画像読取装置
CN109641000A (zh) * 2016-04-14 2019-04-16 Paion英国有限公司 经口吸入和经鼻用的苯并二氮杂*类

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2906265A (en) † 1957-09-03 1959-09-29 Maryland Devices Inc Nasal adaptor for valved dispenser
US4153689A (en) † 1975-06-13 1979-05-08 Takeda Chemical Industries, Ltd. Stable insulin preparation for nasal administration
GB1604644A (en) * 1977-07-22 1981-12-09 Wellcome Found Biologically active pentapeptide amides
US4284648A (en) * 1979-08-03 1981-08-18 The University Of Kentucky Research Foundation Nasal administration of propranolol
US4381773A (en) † 1980-06-23 1983-05-03 Schering Corporation Method and nozzle for nasal vaccination of immature mammals
US4428883A (en) * 1981-03-06 1984-01-31 The University Of Kentucky Research Foundation Novel method of administering β-blockers and novel dosage forms containing same
FR2568773B1 (fr) * 1984-08-10 1989-03-03 Sandoz Lab Nouvelles compositions pharmaceutiques administrables par voie nasale
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
JPH0710771B2 (ja) * 1984-10-23 1995-02-08 ナステツク フア−マス−テイカル カンパニ−、インコ−ポレイテツド 抗吐き気および抗嘔吐薬剤の新規な投与組成物
JPS61267528A (ja) † 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
JP2573275B2 (ja) * 1986-03-10 1997-01-22 ブルグハルト，クルト 薬学的製剤及びその製造法
US4786647A (en) * 1986-06-30 1988-11-22 University Of Florida Method for eliciting anxiolysis

Also Published As

Publication number Publication date
US4950664A (en) 1990-08-21
WO1990002737A1 (en) 1990-03-22
IL91656A0 (en) 1990-04-29
AU4349989A (en) 1990-04-02
KR920005965B1 (ko) 1992-07-25
DE68923697T3 (de) 2001-04-05
EP0386232A4 (en) 1991-03-13
DK175710B1 (da) 2005-01-31
NZ230653A (en) 1991-05-28
DE68923697D1 (de) 1995-09-07
ATE125799T1 (de) 1995-08-15
EP0386232B1 (en) 1995-08-02
JPH03501390A (ja) 1991-03-28
EP0386232B2 (en) 2000-09-06
DK120390A (da) 1990-05-15
KR900701252A (ko) 1990-12-01
EP0386232A1 (en) 1990-09-12
CA1336502C (en) 1995-08-01
JP2729525B2 (ja) 1998-03-18
AU640618B2 (en) 1993-09-02
DE68923697T2 (de) 1996-01-25

Similar Documents

Publication Publication Date Title
DK120390A (da) Nasal administration af benzodiazepinhypnotika
SV1997000049A (es) Conjugados de interferones ref. 12614 sv
MY119365A (en) Novel pharmaceutical combination
NO306377B1 (no) Doseform for avgivelse av et medikament
DK0527835T3 (da) Doseringsform til afgivelse af et anti-Parkinsonmiddel
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
OA09850A (fr) Conjugués d'interféron et composés les contenant.
MY115662A (en) Novel compounds with analgesic effect
DK0600079T3 (da) Oral 1alpha-hydroxyprævitamin D
ATE189400T1 (de) Knochenwachstumsfördernde zusammensetzung
ATE240344T1 (de) Nor-pregnane zur induzierung hypothalamischer effekte
BR9610983A (pt) Formas estáveis de administração farmacêuticas contendo paratormônio
DE69833748D1 (de) Benzocycloheptha-thiophen verbindungen
MY113203A (en) Lyophilizate of lipid complex of water insoluble camptothecins
NZ237930A (en) Wafer for administration of medicaments through the sub-lingual mucosa
ATE134294T1 (de) Zusammensetzung mit psyllium
MY101916A (en) Etoposide oral dosage form.
TR199900013T2 (xx) Yeni bile�ikler.
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
NO902022L (no) Nasal administrering av benzodiazepin-sovemidler.
IT1235539B (it) Composti otticamente attivi a base di nicergolina aventi attivita' vasodilatatrice periferica, e loro composizioni farmaceutiche
CS631190A3 (en) E1 prostaglandin in injection medicinal form

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK